Nachtigal M, Altman A, Arora R, Schweizer F, Arthur G
Cancers (Basel). 2022; 14(14).
PMID: 35884379
PMC: 9322924.
DOI: 10.3390/cancers14143318.
Uriarte N, Ferreno M, Mendez D, Nogueira J
Sci Rep. 2020; 10(1):5479.
PMID: 32214157
PMC: 7096482.
DOI: 10.1038/s41598-020-62163-z.
Trulla L, Magistrelli A, Salmona M, Tacconi M
Lipids. 1993; 28(5):403-6.
PMID: 8316047
DOI: 10.1007/BF02535937.
Hong C, An S, Nechaev A, Kirisits A, Vig R, West C
Lipids. 1993; 28(11):1021-6.
PMID: 8277825
DOI: 10.1007/BF02537125.
Girgert R, Schweizer P, Bock I, Narr R, Bruchelt G
J Cancer Res Clin Oncol. 1995; 121(5):262-6.
PMID: 7768962
DOI: 10.1007/BF01209591.
Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapy.
Heim M, Swoboda M, Pahlke W, Edler L, Bicker U
J Cancer Res Clin Oncol. 1984; 108(3):316-20.
PMID: 6549010
DOI: 10.1007/BF00390465.
Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Berdel W, Von Hoff D, Unger C, Schick H, Fink U, Reichert A
Lipids. 1986; 21(4):301-4.
PMID: 3713449
DOI: 10.1007/BF02536417.
Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.
Herrmann D, Neumann H
Lipids. 1987; 22(11):955-7.
PMID: 3444392
DOI: 10.1007/BF02535563.
Synthesis of thioether phosphocholine analogues.
Bosies E, Herrmann D, Bicker U, Gall R, Pahlke W
Lipids. 1987; 22(11):947-51.
PMID: 3444390
DOI: 10.1007/BF02535561.
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M, Berdel W, Schick H, Fink U, Pahlke W, Bicker U
Lipids. 1987; 22(11):916-8.
PMID: 3444385
DOI: 10.1007/BF02535554.
Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick H, Berdel W, Fromm M, Fink U, Jehn U, Ulm K
Lipids. 1987; 22(11):904-10.
PMID: 3444383
DOI: 10.1007/BF02535552.
Neoplastic cell inhibition with new ether lipid analogs.
Noseda A, Berens M, Piantadosi C, MODEST E
Lipids. 1987; 22(11):878-83.
PMID: 3444381
DOI: 10.1007/BF02535548.
Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types.
Storme G, Bruyneel E, Schallier D, Bolscher J, Berdel W, Mareel M
Lipids. 1987; 22(11):847-50.
PMID: 3444376
DOI: 10.1007/BF02535542.
Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients.
Herrmann D, Neumann H, Berdel W, Heim M, Fromm M, Boerner D
Lipids. 1987; 22(11):962-6.
PMID: 3328028
DOI: 10.1007/BF02535565.
Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
VOGLER W, Olson A, Okamoto S, Somberg L, Glasser L
Lipids. 1987; 22(11):919-24.
PMID: 3328027
DOI: 10.1007/BF02535555.
Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C.
Hofmann J, Ueberall F, Posch L, Maly K, Herrmann D, GRUNICKE H
Lipids. 1989; 24(4):312-7.
PMID: 2755309
DOI: 10.1007/BF02535169.
The chemotherapeutic potential of glycol alkyl ethers: structure-activity studies of nine compounds in a Fischer-rat leukemia transplant model.
Dieter M, Jameson C, Maronpot R, Langenbach R, Braun A
Cancer Chemother Pharmacol. 1990; 26(3):173-80.
PMID: 2357763
DOI: 10.1007/BF02897195.
Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.
Himmelmann A, Steinhauser G, Busch R, MODEST E, Noseda A, Rastetter J
Cancer Chemother Pharmacol. 1990; 26(6):437-43.
PMID: 2225315
DOI: 10.1007/BF02994095.
Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.
Shoji M, Raynor R, Fleer E, Eibl H, VOGLER W, Kuo J
Lipids. 1991; 26(2):145-9.
PMID: 2051897
DOI: 10.1007/BF02544009.
Membrane-interactive lipids as experimental anticancer drugs.
Berdel W
Br J Cancer. 1991; 64(2):208-11.
PMID: 1892746
PMC: 1977494.
DOI: 10.1038/bjc.1991.277.